4DMedical Statistics
Total Valuation
4DMedical has a market cap or net worth of AUD 614.22 million. The enterprise value is 611.64 million.
Market Cap | 614.22M |
Enterprise Value | 611.64M |
Important Dates
The last earnings date was Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
4DMedical has 468.87 million shares outstanding. The number of shares has decreased by -42.02% in one year.
Current Share Class | 465.60M |
Shares Outstanding | 468.87M |
Shares Change (YoY) | -42.02% |
Shares Change (QoQ) | -65.26% |
Owned by Insiders (%) | 3.57% |
Owned by Institutions (%) | 1.22% |
Float | 377.82M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 104.93 |
PB Ratio | 9.56 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -20.34 |
EV / Sales | 104.49 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -17.70 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.07.
Current Ratio | 0.89 |
Quick Ratio | 0.74 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | -0.12 |
Interest Coverage | -188.80 |
Financial Efficiency
Return on equity (ROE) is -44.49% and return on invested capital (ROIC) is -41.63%.
Return on Equity (ROE) | -44.49% |
Return on Assets (ROA) | -28.02% |
Return on Invested Capital (ROIC) | -41.63% |
Return on Capital Employed (ROCE) | -63.74% |
Revenue Per Employee | 40,368 |
Profits Per Employee | -207,378 |
Employee Count | 145 |
Asset Turnover | 0.05 |
Inventory Turnover | 0.49 |
Taxes
Income Tax | -87,118 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +204.65% in the last 52 weeks. The beta is 1.36, so 4DMedical's price volatility has been higher than the market average.
Beta (5Y) | 1.36 |
52-Week Price Change | +204.65% |
50-Day Moving Average | 0.41 |
200-Day Moving Average | 0.39 |
Relative Strength Index (RSI) | 88.43 |
Average Volume (20 Days) | 6,417,810 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 4DMedical had revenue of AUD 5.85 million and -30.07 million in losses. Loss per share was -0.14.
Revenue | 5.85M |
Gross Profit | 5.39M |
Operating Income | -48.16M |
Pretax Income | -30.16M |
Net Income | -30.07M |
EBITDA | -45.82M |
EBIT | -48.16M |
Loss Per Share | -0.14 |
Balance Sheet
The company has 6.88 million in cash and 4.31 million in debt, giving a net cash position of 2.57 million or 0.01 per share.
Cash & Cash Equivalents | 6.88M |
Total Debt | 4.31M |
Net Cash | 2.57M |
Net Cash Per Share | 0.01 |
Equity (Book Value) | 64.24M |
Book Value Per Share | 0.16 |
Working Capital | -2.19M |
Cash Flow
In the last 12 months, operating cash flow was -34.48 million and capital expenditures -85,838, giving a free cash flow of -34.56 million.
Operating Cash Flow | -34.48M |
Capital Expenditures | -85,838 |
Free Cash Flow | -34.56M |
FCF Per Share | -0.07 |
Margins
Gross Margin | 92.07% |
Operating Margin | -822.76% |
Pretax Margin | -515.20% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
4DMedical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 42.02% |
Shareholder Yield | n/a |
Earnings Yield | -4.90% |
FCF Yield | -5.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
4DMedical has an Altman Z-Score of -0.76 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.76 |
Piotroski F-Score | 1 |